APOE and lymphedema: The interaction between APOE4 and MLVs appears to play a role in AD [137]: APOE4 is likely linked to reduced expression of lymphatic vessel genetic markers and peripheral lymphedema-associated genes, and therefore, APOE4’s action could result in the early shrinkage and attenuated function of MLVs, diminishing CSF flow and decreasing Aβ clearance.